Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$264K Buy
9,267
+799
+9% +$21.3K 0.11% 135
2026
Q2
$204K Buy
8,468
+417
+5% +$10.9K 0.09% 160
2026
Q1
$226K Buy
+8,051
New +$214K 0.13% 151

Other funds holding PFE

EJMK Ventures's PFE Position: Q3 2026 in Review

EJMK Ventures increased its Pfizer (PFE) stake by 9.4% in Q3 2026, buying an estimated $21.3K and bringing the position to 9,267 shares worth $264K. The position accounts for 0.11% of the portfolio, ranked #135.

EJMK Ventures first reported a position in PFE in Q1 2026 and has held it in 3 quarters since. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • EJMK Ventures held 9,267 shares of Pfizer worth $264K as of Q3 2026.
  • EJMK Ventures bought 799 Pfizer shares in Q3 2026, an estimated $21.3K.
  • Pfizer made up 0.11% of EJMK Ventures's portfolio in Q3 2026, its #135 holding.
  • EJMK Ventures first reported a position in Pfizer in Q1 2026 and has held it in 3 quarters since.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on EJMK Ventures's 13F filing for Q3 2026, filed 21 Oct 2026.